Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Efficacy and Safety of Infliximab Monotherapy or in Combination With Azathioprine in the Treatment of Crohn's Disease in Children

NCT07424040 is registered in ClinicalTrials.gov with The Children's Hospital of Zhejiang University School of Medicine as lead sponsor.

NCT NCT07424040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07424040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Efficacy and Safety of Infliximab Monotherapy or in Combination With Azathioprine in the Treatment of Crohn's Disease in Children
Lead sponsor
The Children's Hospital of Zhejiang University School of Medicine
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
November 30, 2028
Enrollment
154 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease in pediatric patient, crohn's diseases